- Short report
- Open Access
HHV-8 reduces dendritic cell migration through down-regulation of cell-surface CCR6 and CCR7 and cytoskeleton reorganization
© Cirone et al.; licensee BioMed Central Ltd. 2012
- Received: 10 January 2012
- Accepted: 14 May 2012
- Published: 14 May 2012
For an efficient immune response against viral infection, dendritic cells (DCs) must express a coordinate repertoire of receptors that allow their recruitment to the sites of inflammation and subsequently to the secondary lymphoid organs in response to chemokine gradients.
Several pathogens are able to subvert the chemokine receptor expression and alter the migration properties of DCs as strategy to escape from the immune control.
Here we report the inhibitory effect of Human Herpesvirus 8 (HHV-8) on the migratory behavior of immature and mature DCs. We found that the virus altered the DC chemokine receptor expression and chemokine induced migration. Moreover HHV-8 was also able to interfere with basal motility of DCs by inducing cytoskeleton modifications.
Based on our findings, we suggest that HHV-8 is able to subvert the DC migration capacity and this represents an additional mechanism which interferes with their immune-functions.
- Chemokine receptors
- Dendritic cells.
Dendritic cells (DCs) are critical for initiating an adaptive immune response against microbial and tumor antigens . Their function is strictly linked to their migration properties along chemokine gradients and other chemotactic factors . Immature DCs (iDCs) and their precursors are recruited to the infection and inflammatory sites in response to inflammatory chemokines such as MIP1 alfa and beta, CCL5/Rantes and CCL20 which bind to the chemokine receptors CCR1, CCR5, CCR2 and CCR6 respectively [3–5].In the peripheral tissues, DCs can initiate the antigen uptake and processing which, together with the exposure to inflammatory signals, results in DC maturation. This process is followed by switch of the chemokines receptor repertoire, e.g. downregulation of CCR5 and upregulation of CCR7, which drives their migration to secondary lymphoid organs mainly in response to the CCL19 chemokine . To evade immune control, several viruses have been shown to interfere with the migratory capacity of DCs, as well as with their differentiation and maturation process. Vaccinia virus impairs migration and receptor switch of infected and bystander DCs , Human Respiratory Syncitial virus , Herpes Simplex virus  and Cytomegalovirus alter the chemokine-mediated migration by downregulating CCR1, CCR5  and CCR7  chemokine receptors on immature and mature DCs. Human Herpesvirus 8 (HHV-8), an oncogenic virus associated to Kaposi’s Sarcoma and Primary Effusion Lymphoma  has been previously shown to interfere with DC function  and impair the in vitro monocyte differentiation into DCs . Here we asked if HHV-8 is also able to alter the pattern of chemokine receptor expression of monocyte-derived DCs and interfere with their migratory capacity.
This work was partially supported by grants from MIUR, Associazione Italiana per la ricerca sul Cancro (AIRC), progetto strategico ISS 9ACF/1 of Ministero della salute and Pasteur Cenci-Bolognetti foundation.
- Banchereau J, Breire F, Caux C, Davoust J, Lebecque S, Liu YJ, Puledran B, Palucka K: Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18: 767-811. 10.1146/annurev.immunol.18.1.767PubMedView ArticleGoogle Scholar
- Sozzani S, Allavena P, Vecchi A, Mantovani A: Chemokines and dendritic cell traffic. J Clin Immunol 2000, 20: 151-160. 10.1023/A:1006659211340PubMedView ArticleGoogle Scholar
- Sozzani S, Luini W, Borsatti A, Polentarutti N, Zhou D, Piemonti L, D'Amico G, Power CA, Wells TN, Gobbi M, Allavena P, Mantovani A: Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol 1997, 159: 1993-2000.PubMedGoogle Scholar
- Caux C, Ait-Yahia S, Chemin K, de Bouteiller O, Dieu-Nosjean MC, Homey B, Massacrier C, Vanbervliet B, Zlotnik A, Vicari A: Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin Immunopathol 2000, 22: 345-369. 10.1007/s002810000053PubMedView ArticleGoogle Scholar
- Kallal LE, Schaller MA, Lindell DM, Lira SA, Lukacs NW: CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment of DC. Eur J Immunol. 2010, 40: 1042-1052. 10.1002/eji.200939778PubMedPubMed CentralView ArticleGoogle Scholar
- Förster R, Davalos-Misslitz AC, Rot A: CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 2008, 8: 362-371. 10.1038/nri2297PubMedView ArticleGoogle Scholar
- Humrich JY, Thumann P, Greiner S, Humrich JH, Averbeck M, Schwank C, Kämpgen E, Schuler G, Jenne L: Vaccinia virus impairs directional migration and chemokine receptor switch of human dendritic cells. Eur J Immunol 2007, 37: 954-965. 10.1002/eji.200636230PubMedView ArticleGoogle Scholar
- Grayson MH, Ramos MS, Rohlfing MM, Kitchens R, Wang HD, Gould A, Agapov E, Holtzman MJ: Controls for lung dendritic cell maturation and migration during respiratory viral infection. J Immunol 2007, 179: 1438-1348.PubMedView ArticleGoogle Scholar
- Prechtel AT, Turza NM, Kobelt DJ, Eisemann JI, Coffin RS, McGrath Y, Hacker C, Ju X, Zenke M, Steinkasserer A: Infection of mature dendritic cells with herpes simplex virus type 1 dramatically reduces lymphoid chemokine-mediated migration. J Gen Virol 2005, 86: 1645-1657. 10.1099/vir.0.80852-0PubMedView ArticleGoogle Scholar
- Varani S, Frascaroli G, Homman-Loudiyi M, Feld S, Landini MP, Söderberg-Nauclér C: Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5. J Leukoc Biol 2005, 77: 219-228.PubMedView ArticleGoogle Scholar
- Moutaftsi M, Brennan P, Spector SA, Tabi Z: Impaired lymphoid chemokine-mediated migration due to a block on the chemokine receptor switch in human cytomegalovirus-infected dendritic cells. J Virol 2004, 78: 3046-3054. 10.1128/JVI.78.6.3046-3054.2004PubMedPubMed CentralView ArticleGoogle Scholar
- Boshoff C, Weiss R: AIDS-related malignancies. Nat Rev Cancer 2002, 2: 373-382. 10.1038/nrc797PubMedView ArticleGoogle Scholar
- Rappocciolo G, Jenkins FJ, Hensler HR, Piazza P, Jais M, Borowski L, Watkins SC, Rinaldo CR: DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages. J Immunol 2006, 17: 1741-1749.View ArticleGoogle Scholar
- Cirone M, Lucania G, Bergamo P, Trivedi P, Frati L, Faggioni A: Human herpesvirus 8 (HHV-8) inhibits monocyte differentiation into dendritic cells and impairs their immunostimulatory activity. Immunol Lett 2007, 113: 40-46. 10.1016/j.imlet.2007.07.013PubMedView ArticleGoogle Scholar
- Lallemand F, Desire N, Rozenbaum W, Nicolas JC, Marechal V: Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay. J Clin Microbiol 2000, 38: 1404-1408.PubMedPubMed CentralGoogle Scholar
- Schutyser E, Struyf S, Van Damme J: The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 2003, 14: 409-426. 10.1016/S1359-6101(03)00049-2PubMedView ArticleGoogle Scholar
- Allavena P, Sica A, Vecchi A, Locati M, Sozzani S, Mantovani A: The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues. Immunol Rev 2000, 177: 141-149. 10.1034/j.1600-065X.2000.17714.xPubMedView ArticleGoogle Scholar
- Cunningham AL, Donaghy H, Harman AN, Kim M, Turville SG: Manipulation of dendritic cell function by viruses. Curr Opin Microbiol 2010, 13: 524-529. 10.1016/j.mib.2010.06.002PubMedView ArticleGoogle Scholar
- Hensler HR, Rappocciolo G, Rinaldo CR, Jenkins FJ: Cytokine production by human herpesvirus 8-infected cells. J Gen Virol 2009, 90: 79-83. 10.1099/vir.0.006239-0PubMedPubMed CentralView ArticleGoogle Scholar
- Theodoridis AA, Eich C, Figdor CG, Steinkasserer A: Infection of dendritic cells with herpes simplex type 1 induces rapid degradation of CYTIP, thereby modulating adhesion and migration. Blood 2011, 118: 105-115.View ArticleGoogle Scholar
- Nefedova Y, Huang M, Kusmartsev S, Battacharya R, Cheng P, Salup R, Jove R, Gabrilovich D: Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer. J. Immunol. 2004, 172: 464-474.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.